Diagnostic performance of placental growth factor in women with suspected preeclampsia attending antenatal facilities in Maputo, Mozambique

Hypertension

Volumn 69, Issue 3, 2017, Pages 469-474

  Ukah, U Vivian ^a   Mbofana, Francisco ^b   Rocha, Beatriz Manriquez ^c   Loquiha, Osvaldo ^d   Mudenyanga, Chishamiso ^c   Usta, Momade ^e   Urso, Marilena ^f   Drebit, Sharla ^a   Magee, Laura A ^g,h   Von Dadelszen, Peter ^g,h  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MINISTRY OF HEALTH   (Mozambique)

^c CLINTON HEALTH ACCESS INITIATIVE   (United States)

^d EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^e J Macamo Hospital   (Mozambique)

^f Centre for Collaboration in Health (CCS)   (Mozambique)

^g ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^h ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

birth weight; blood pressure; fetal death; pre eclampsia; pregnancy

Indexed keywords

CREATININE; PLACENTAL GROWTH FACTOR;

ADULT; ARTICLE; BLOOD PRESSURE; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL PLASMA; MOZAMBIQUE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT; BLOOD; CLINICAL TRIAL; FOLLOW UP; INCIDENCE; MULTICENTER STUDY; PRE-ECLAMPSIA; PREGNANCY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS;

ADULT; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INCIDENCE; MOZAMBIQUE; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 85011298640     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08547     Document Type: Article

References (23)

1. von Dadelszen P, Magee LA., Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2016 36 83 102. doi: 10.1016/j.bpobgyn.2016.05.005
2. Say L, Chou D, Gemmill A, Tunçalp Ö Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L., Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014 2 e323 e333. doi: 10.1016/S2214-109X(14)70227-X
3. Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyr GJ., Pre-eclampsia. Lancet 2016 387 999 1011. doi: 10.1016/S0140-6736(15)00070-7
4. Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, Charnock-Jones DS, Redman CW., Redefining preeclampsia using placenta-derived biomarkers. Hypertension 2013 61 932 942. doi: 10.1161/HYPERTENSIONAHA.111.00250
5. Payne BA, Hutcheon JA, Ansermino JM, miniPIERS Study Working Group A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study. PLoS Med 2014 11 e1001589. doi: 10.1371/journal.pmed.1001589
6. Payne BA, Hutcheon JA, Dunsmuir D, Cloete G, Dumont G, Hall D, Lim J, Magee LA, Sikandar R, Qureshi R, van Papendorp E, Ansermino JM, von Dadelszen P., Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model. J Obstet Gynaecol Can 2015 37 16 24
7. von Dadelszen P, Payne B, Li J, PIERS Study Group Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011 377 219 227. doi: 10.1016/S0140-6736(10)61351-7
8. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006 355 992 1005. doi: 10.1056/NEJMoa055352
9. Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, von Dadelszen P., Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol 2011 205 469.e1 469.e8. doi: 10.1016/j.ajog.2011.06.058
10. Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, Simpson N, Waugh J, Anumba D, Kenny LC, Redman CW, Shennan AH., Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 2013 128 2121 2131. doi: 10.1161/CIRCULATIONAHA.113.003215
11. Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P, Poston L, Chappell LC., Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 2016 89 874 885. doi: 10.1016/j.kint.2015.10.012
12. Benton SJ, McCowan LM, Heazell AE, Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta 2016 42 1 8. doi: 10.1016/j.placenta.2016.03.010
13. Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, Connor JM, Dobbie R., Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 2007 109 1316 1324. doi: 10.1097/01.AOG.0000265804.09161.0d
14. Dunand C, Hoffmann P, Sapin V, Blanchon L, Salomon A, Sergent F, Benharouga M, Sabra S, Guibourdenche J, Lye SJ, Feige JJ, Alfaidy N., Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition. Biol Reprod 2014 91 73. doi: 10.1095/biolreprod.114.119990
15. Boene H, Vidler M, Sacoor C, Nhama A, Nhacolo A, Bique C, Alonso P, Sawchuck D, Qureshi R, Macete E, Menéndez C, von Dadelszen P, Sevene E, Munguambe K., Community perceptions of pre-eclampsia and eclampsia in southern Mozambique. Reprod Health 2016 13(Suppl 1) 33. doi: 10.1186/s12978-016-0135-y
16. Munguambe K, Boene H, Vidler M, Bique C, Sawchuck D, Firoz T, Makanga PT, Qureshi R, Macete E, Menéndez C, von Dadelszen P, Sevene E., Barriers and facilitators to health care seeking behaviours in pregnancy in rural communities of southern Mozambique. Reprod Health 2016 13(Suppl 1) 31. doi: 10.1186/s12978-016-0141-0
17. Boene H, Vidler M, Augusto O, Sidat M, Macete E, Menéndez C, Sawchuck D, Qureshi R, von Dadelszen P, Munguambe K, Sevene E, CLIP Feasibility Working Group Community health worker knowledge and management of pre-eclampsia in southern Mozambique. Reprod Health 2016 13 Suppl 2 105. doi: 10.1186/s12978-016-0220-2
18. Firoz T, Vidler M, Makanga PT, Boene H, Chiaú R, Sevene E, Magee LA, von Dadelszen P, Munguambe K, CLIP Working Group Community perspectives on the determinants of maternal health in rural southern Mozambique: a qualitative study. Reprod Health 2016 13 Suppl 2 112. doi: 10.1186/s12978-016-0217-x
19. Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, Simpson N, Waugh J, Anumba D, Kenny LC, Redman CW, Shennan AH., Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 2013 128 2121 2131. doi: 10.1161/CIRCULATIONAHA.113.003215
20. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA., The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens 2014 4 97 104. doi: 10.1016/j.preghy.2014.02.001
21. Villar J, Cheikh Ismail L, Victora CG, International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 2014 384 857 868. doi: 10.1016/S0140-6736(14)60932-6
22. Saffer C, Olson G, Boggess KA, Beyerlein R, Eubank C, Sibai BM, NORMALS Study Group Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertens 2013 3 124 132. doi: 10.1016/j.preghy.2013.01.004
23. Rasanen J, Quinn MJ, Laurie A, Bean E, Roberts CT Jr, Nagalla SR, Gravett MG., Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia. Am J Obstet Gynecol 2015 212 82.e1 82.e9. doi: 10.1016/j.ajog.2014.07.052